Clinical Trials Sponsored by Alzheimer Europe

Total 2994 results

Hearthstone Alzheimer Care
Abbott

Unknown

Study of Depakote for Behavioral and Psychological Symptoms in Dementia

Dementia

United States
Innovation Alzheimer
Centre Hospitalier Universitaire de Nice; Alzheimer's Association; Université...

Completed

Efficacy of the Memory Motivation (MEMO) Web Application Training (MeMo)

Neurocognitive Disorders

France
Biosensors Europe SA
European Cardiovascular Research Center

Recruiting

eUltra 10k - Biofreedom Ultra

Post Market Clinical Follow up (PMCF)

United Kingdom
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM

Ischemia | Coronary Artery Disease | Acute Coronary Syndrome | Stable Angina | STEMI | NSTEMI

United Kingdom
Biosensors Europe SA
European Cardiovascular Research Center

Active, not recruiting

BioFreedom French Registry

Coronary Artery Disease

France
Biosensors Europe SA
European Cardiovascular Research Center

Completed

e-BioMatrix 6 Month DAPT France

Ischemia | Stable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MI | Coronary Artery Stenoses
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

A Randomized Clinical Evaluation of the BioFreedom™ Stent (Leaders Free)

Bleeding | Stable Angina | In-stent Coronary Artery Restenosis | Ischemic Heart Disease Silent | ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction

Switzerland
Biosensors Europe SA
European Cardiovascular Research Center

Completed

Leaders Free III: BioFreedom™ Clinical Trial

Myocardial Infarction | Mortality | Bleeding | Cardiac Death | Stent Thrombosis

France, Switzerland
Hasselt University
Stichting Alzheimer Onderzoek

Recruiting

Adherence by Music to Exercise in Dementia: Group Therapy (AMUSED)

Dementia

Belgium
University Hospital, Lille
France Alzheimer

Unknown

Nonverbal Communication in Aged People (MAMUS)

Alzheimer Disease

France
European University Miguel de Cervantes
Asociación de Familiares de Alzheimer de Valladolid

Completed

Influence of Physical Exercise as Adjuvant Treatment in Patients With Alzheimer's Disease

Alzheimer Disease

Spain
University Hospital, Lille
France Alzheimer

Not yet recruiting

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders (SOCIALIZE)

Alzheimer's Disease | Frontotemporal Degeneration (Semantic & Behavioral Variants)
University Hospital, Toulouse
France Alzheimer

Recruiting

Cohort of Patients With Alzheimer's Disease and Their Families. (ALFA3pilot)

Alzheimer Disease

France
Dalhousie University
Alzheimer Society of Canada

Not yet recruiting

Dementia Moves: Protocol for a Feasibility Study

Moderate to Severe Dementia
McMaster University
Alzheimer Society of Canada

Completed

Supporting Caregivers of Persons With Dementia: A Pilot Study

Dementia | Alzheimer Disease

Canada
JANSSEN Alzheimer Immunotherapy Research & Development...

Terminated

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Vaccinex Inc.
Alzheimer's Association; Alzheimer's Drug Discovery Foundation

Active, not recruiting

SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) (SIGNAL-AD)

Alzheimer Disease

United States
Baycrest
Alzheimer's Society

Not yet recruiting

Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease

Alzheimer Disease

Canada
University Hospital, Toulouse
Fondation Plan Alzheimer

Completed

Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients (VIP)

Alzheimer Disease

France
University Hospital, Bordeaux
Fondation Plan Alzheimer

Completed

A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders (MEMENTO)

Alzheimer's Disease (AD) and Related Disorders

France
Lakehead University
Alzheimer Society of Canada

Completed

Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses (MBCT_AD)

Dementia
Leiden University Medical Center
Alzheimer Nederland

Recruiting

WHIte MAtter Hyperintensity Shape and Glymphatics (WHIMAS)

Cognitive Impairment | Mild Cognitive Impairment | Cerebral Small Vessel Diseases | Dementia, Vascular | Cognitive Decline | Dementia, Mixed

Netherlands
Fundacion CITA-alzheimer
Biogipuzkoa Health Research Institute

Completed

GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia. (GOIZ_ZAINDU)

Cognitive Decline | Prevention | Dementia Risk Factors | Multidomain Intervention

Spain
Charite University, Berlin, Germany
German Alzheimer Society

Completed

Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care (VODINO)

Dementia

Germany
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

Alzheimer Disease

United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Japan
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Terminated

Retrieval of Patient Information After Discontinuation (RAPID)

Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (ACCTION)

Alzheimer's Disease

United States
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease (SUMMIT AD)

Alzheimer's Disease

United States
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Terminated

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Canada, Austria
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Alzheimer's Disease

United States, Germany, Canada, Austria
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Alzheimer's Disease

United States
Lynkcell Europe

Enrolling by invitation

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Breast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA Mutation

Ukraine
Metagenics Europe

Terminated

Evaluation of a Nutraceutical for Endometriosis Pain Relief

Endometriosis

Belgium
AOSpine Europe

Completed

Surgical Treatment for Spinal Cord Injury (SCI-POEM)

Acute Spinal Cord Injury of Traumatic Origin (tSCI)

United Kingdom, Ireland, Austria, Italy, Netherlands, Bulgaria, Croatia, France, Germany, Romania, Serbia, Turkey
Lynkcell Europe

Available

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Kidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Amylyx Pharmaceuticals Inc.
Alzheimer's Association; Alzheimer's Drug Discovery Foundation

Completed

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (PEGASUS)

Alzheimer Disease

United States
Alzheimer's Light LLC

Recruiting

Longitudinal Cognitive Assessment by BoCA (BoCA)

Multiple Sclerosis | Parkinson Disease | Alzheimer Disease | Mild Cognitive Impairment | Frontotemporal Dementia | Vascular Dementia | TBI

United States
Kinto
Alzheimer's Association

Completed

Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers

Dementia | Alzheimer Disease | Lewy Body Disease | Frontotemporal Dementia | Vascular Dementia | Mixed Dementia

United States
Alzheimer's Light LLC

Recruiting

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy (AlzLife)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognition Disorders in Old Age

United States
Korean Alzheimers' Disease Neuroimaing Intitiative

Unknown

Korea Alzheimer's Disease Neuroimaging Initiative (K-ADNI)

Mild Cognitive Impairment | Alzheimer's Disease | Subcortical Vascular Dementia

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
France Alzheimer

Recruiting

The Ketogenic Diet for Alzheimer's Disease (CETOMA)

Alzheimer Disease, Early Onset

France
Assistance Publique - Hôpitaux de Paris
France Alzheimer

Recruiting

Donepezil Versus Non-drug Treatment in Alzheimer's Disease. (CHOLINE-2)

Alzheimer Disease, Early Onset

France
Fondation Mederic Alzheimer
Malakoff-Humanis; Siel Bleu

Completed

Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes

Dementia | Relation, Family

France
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Spain, France, Germany
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of, United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Alzheimer's Disease

United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan

Clinical Trials Sponsored by Alzheimer Europe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations